Gelteq Ltd

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

GELSNasdaqHealthcareDrug Manufacturers - Specialty & Generic
$0.50 -0.02 (-3.31%)

Company Overview

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Price Chart

Historical Trend (Absolute Values)
GELS Price
05/2005/2906/05

Financial Metrics

Market Capitalization$5.32M
P/E Ratio
Earnings Per Share (EPS)-$1
Dividend Yield
Beta (Volatility)
Price to Book (P/B)0.4392
52-Week Range$0.39 - $3.51

LAST SCRARED: June 6, 2026

Compare GELS

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.